Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Glioma × Lomustine × Clear all

Phase

Phase 3 5 Phase 2 4 Phase 1 3 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Recurrence 2 Astrocytoma 2 Oligodendroglioma 1 Glioma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

trametinib 1 dabrafenib 1 cobimetinib 1 carbon-11 acetate 1 Vemurafenib 1 Temozolomide 1 Magnetic Resonance Spectroscopy 1 Lomustine 1 Ga(III)-DOTATOC 1 Disulfiram 1 Copper 1 Carbon-11 1 Alkylating Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02678975 2021-03-18

Disulfiram in Recurrent Glioblastoma

Sahlgrenska University Hospital

Phase 2/3 Completed

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡